BRPI0314882B8 - processo para preparar uma composição tópica contendo acetonida de fluocinolona, hidroquinona e tretinonína para aplicação tópica e composição - Google Patents

processo para preparar uma composição tópica contendo acetonida de fluocinolona, hidroquinona e tretinonína para aplicação tópica e composição

Info

Publication number
BRPI0314882B8
BRPI0314882B8 BRPI0314882A BR0314882A BRPI0314882B8 BR PI0314882 B8 BRPI0314882 B8 BR PI0314882B8 BR PI0314882 A BRPI0314882 A BR PI0314882A BR 0314882 A BR0314882 A BR 0314882A BR PI0314882 B8 BRPI0314882 B8 BR PI0314882B8
Authority
BR
Brazil
Prior art keywords
topical
composition
hydroquinone
preparing
tretinonine
Prior art date
Application number
BRPI0314882A
Other languages
English (en)
Other versions
BRPI0314882B1 (pt
BR0314882A (pt
Inventor
Roth Jerry
Puglia Nancy
Ramirez Rosario
Original Assignee
Galderma Sa
Hill Dermaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Sa, Hill Dermaceuticals Inc filed Critical Galderma Sa
Publication of BR0314882A publication Critical patent/BR0314882A/pt
Publication of BRPI0314882B1 publication Critical patent/BRPI0314882B1/pt
Publication of BRPI0314882B8 publication Critical patent/BRPI0314882B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"composição para tratamento tópico da pele". a presente invenção refere-se a uma base de creme para a aplicação tópica de produtos terapêuticos para tratamento da pele e um processo para preparar a base de creme. em uma modalidade, o produto terapêutico é tretinoína, hidroquinona e acetonida de fluocinolona para o tratamento de condições de pele hiperpigmentada, tais como melasma.
BRPI0314882A 2002-10-25 2003-10-24 processo para preparar uma composição tópica contendo acetonida de fluocinolona, hidroquinona e tretinonína para aplicação tópica e composição BRPI0314882B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/280,483 2002-10-25
US10/280,483 US7544674B2 (en) 2002-10-25 2002-10-25 Topical skin care composition
PCT/US2003/033876 WO2004037201A2 (en) 2002-10-25 2003-10-24 Topical skin care composition

Publications (3)

Publication Number Publication Date
BR0314882A BR0314882A (pt) 2005-08-09
BRPI0314882B1 BRPI0314882B1 (pt) 2018-01-02
BRPI0314882B8 true BRPI0314882B8 (pt) 2021-05-25

Family

ID=32106953

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0314882A BRPI0314882B8 (pt) 2002-10-25 2003-10-24 processo para preparar uma composição tópica contendo acetonida de fluocinolona, hidroquinona e tretinonína para aplicação tópica e composição

Country Status (19)

Country Link
US (8) US7544674B2 (pt)
EP (2) EP1562531B1 (pt)
JP (2) JP4638234B2 (pt)
KR (2) KR100851789B1 (pt)
CN (1) CN1738587B (pt)
AU (1) AU2003284353B9 (pt)
BR (1) BRPI0314882B8 (pt)
CA (1) CA2503539A1 (pt)
CY (1) CY1117292T1 (pt)
DK (1) DK1562531T3 (pt)
ES (1) ES2565317T3 (pt)
HK (2) HK1088831A1 (pt)
HU (1) HUE028549T2 (pt)
MX (1) MXPA05004404A (pt)
PL (1) PL219020B1 (pt)
PT (1) PT1562531E (pt)
RU (1) RU2350313C2 (pt)
SI (1) SI1562531T1 (pt)
WO (1) WO2004037201A2 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7544674B2 (en) 2002-10-25 2009-06-09 Galderma S.A. Topical skin care composition
US20060099173A1 (en) * 2003-10-24 2006-05-11 Nancy Puglia Topical skin care composition
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8449867B2 (en) 2004-08-31 2013-05-28 Stiefel Research Australia Pty Ltd Microemulsion and sub-micron emulsion process and compositions
ES2429040T5 (es) 2004-08-31 2017-06-13 Stiefel Research Australia Pty Ltd Método y composiciones de microemulsión y emulsión submicrónica
US8080560B2 (en) 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
FR2894474B1 (fr) * 2005-12-12 2008-04-11 Galderma Res & Dev Gel depigmentant hydroalcoolique
FR2894482A1 (fr) * 2005-12-14 2007-06-15 Galderma Sa Utilisation d'une composition comprenant une association d'hydroquinone,d'acetonide de fluocinolone et de tretinoine, dans le traitement d'l'hyperpigmentation de la peau suite au psoriasis ou a l'eczema
FR2894479A1 (fr) * 2005-12-14 2007-06-15 Galderma Sa Utilisation d'une composition a base de tretinoine, d'hydroquinone et d'acetonide de fluocinolone, en accompagnement d'un peeling chimique
FR2894481A1 (fr) * 2005-12-14 2007-06-15 Galderma Sa Utilisation d'une composition dermatologique comprenant une association d'hydroquinone, d'acetonide de fluocinolone et de tretinoine, destinee au traitement de l'hyperpigmentation des peaux non caucasiennes
US20070166273A1 (en) * 2006-01-19 2007-07-19 Krivulka Joseph J Skin treatment educational kit
FR2900340B1 (fr) * 2006-04-28 2010-07-30 Galderma Sa Utilisation d'une composition dermatologique comprenant une association d'hydroquinone, d'acetonide de fluocinolone et de tretinoine dans le traitement de l'hyperpigmentation de cicatrices
FR2901134B1 (fr) * 2006-05-19 2008-10-03 Galderma Sa Utilisation d'une composition comprenant une association d'hydroquinone, d'acetonide de fluocinolone, et de tretinoine, destinee au traitement des signes cutanes du photovieillissement
JP2011513192A (ja) * 2007-02-26 2011-04-28 ガルデルマ・リサーチ・アンド・デヴェロップメント 皮膚の脱色における使用のためのフルオシノロンアセトニドを含む局所用組成物
KR100905132B1 (ko) 2007-08-21 2009-06-29 강효신 젤 로션 제조 방법
CN101249095B (zh) * 2007-10-08 2011-08-31 重庆医药工业研究院有限责任公司 一种含脱色剂、维a酸和皮质类固醇的乳膏的制备方法
WO2012053009A2 (en) * 2010-10-21 2012-04-26 Cadila Healthcare Limited Pharmaceutical compositions comprising skin whitening agents
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
RU2450836C1 (ru) * 2011-03-15 2012-05-20 Закрытое акционерное общество Фармацевтическое научно-производственное предприятие "Ретиноиды" Комбинированная мазевая композиция для уменьшения интенсивности локальной гиперпигментации кожи
RU2500395C1 (ru) * 2012-12-07 2013-12-10 Закрытое акционерное общество Фармацевтическое научно-производственное предприятие "Ретиноиды" Мазевая композиция для местного применения с противоугревой фармакологической активностью
JPWO2015053401A1 (ja) * 2013-10-10 2017-03-09 淳 岡部 クリーム状化粧料、及び、その製造方法
BR112016011111B1 (pt) 2013-12-04 2022-11-16 Boehringer Ingelheim Vetmedica Gmbh Composições farmacêuticas aprimoradas de pimobendan
KR101661694B1 (ko) * 2014-07-29 2016-10-10 동아제약 주식회사 히드로퀴논을 포함하는 저자극성 피부 미백용 조성물
EP3236903B1 (en) 2014-12-23 2021-04-21 Intellectual Property Associates, LLC Methods and formulations for transdermal administration
WO2016205001A1 (en) 2015-06-18 2016-12-22 Valeant Pharmaceuticals North America Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis
EP3456314A1 (en) * 2017-09-14 2019-03-20 Tiofarma B.V. Topical formulation comprising 17-ketolic corticosteroid
EP3681479B1 (en) 2017-09-15 2024-01-31 Dyve Biosciences, Inc. Sodium bicarbonate for use in the treatment of gout and related disorders
JP7262227B2 (ja) * 2017-10-23 2023-04-21 マルホ株式会社 被膜形成外用剤
CA3117108C (en) 2018-11-02 2024-01-30 Johnson & Johnson Consumer Inc. Foamable solid cleanser comprising magnesium sulfate
CN110025493A (zh) * 2019-03-01 2019-07-19 浙江孚诺医药股份有限公司 一种不含防腐剂的局部皮肤护理组合物及其制备工艺
CN110559257A (zh) * 2019-09-19 2019-12-13 湖北科益药业股份有限公司 一种咪喹莫特泡囊凝胶剂及其制备方法
CN112022806B (zh) * 2020-04-09 2022-04-15 广东人人康药业有限公司 一种油包水型的氢醌乳剂及其制备方法和其应用
US20230277425A1 (en) * 2020-07-08 2023-09-07 Lg Household & Health Care Ltd. Hydroquinone stabilizing composition
KR102689535B1 (ko) * 2020-10-29 2024-07-29 주식회사 엘지생활건강 히드로퀴논 또는 이의 유도체를 함유하는 안정화 조성물

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2164723A (en) * 1939-07-04 Emulsions
US1429430A (en) * 1921-04-27 1922-09-19 Harry N Holmes Emulsion
US3226295A (en) * 1960-02-08 1965-12-28 Carlos C Goetz Method of making cetyl alcohol emulsions
US3856934A (en) * 1970-06-24 1974-12-24 A Kligman Skin depigmentation
US3776857A (en) * 1971-09-24 1973-12-04 Witco Chemical Corp Water-in-oil emulsions
US3906108A (en) * 1973-10-12 1975-09-16 Johnson & Johnson Stabilized tretinoin cream emulsion
JPS5729213B2 (pt) * 1974-11-12 1982-06-21
US3966924A (en) * 1974-11-13 1976-06-29 Allergan Pharmaceuticals Composition and method for treating psoriasis
US4146499A (en) * 1976-09-18 1979-03-27 Rosano Henri L Method for preparing microemulsions
JPS56135416A (en) * 1980-03-27 1981-10-22 Mitsubishi Chem Ind Ltd Pharmaceutical preparation for skin
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
IT1157269B (it) * 1982-03-19 1987-02-11 Seuref Ag Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica
US4489071A (en) * 1983-12-09 1984-12-18 Schering Corporation Betamethasone dipropionate cream
US4603046A (en) * 1985-08-23 1986-07-29 Charles Of The Ritz Group Ltd. Improved sunscreen or sunblock composition
US4737360A (en) * 1986-01-24 1988-04-12 Cernitin America, Inc. Skin care compositions
US5651991A (en) * 1987-10-28 1997-07-29 Nippon Shinyaku Co. Ltd. Drug carriers
JP2652395B2 (ja) 1988-02-09 1997-09-10 株式会社資生堂 乳化組成物及び乳化化粧料
US4992478A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4857321A (en) * 1988-08-26 1989-08-15 Thomas William C Skin ointment
US5171737A (en) * 1989-03-03 1992-12-15 The Liposome Company, Inc. Emulsions
US5145604A (en) * 1990-09-19 1992-09-08 S. C. Johnson & Son, Inc. Aqueous emulsion and aerosol delivery system using same
FR2695036B1 (fr) * 1992-09-03 1994-10-28 Goupil Jean Jacques Huile contenant du 5-méthoxypsoralène à une concentration de 60 à 100 PPM et son utilisation pour le traitement du psoriasis.
US5645854A (en) 1993-06-23 1997-07-08 Masiz; John J. Molecular transdermal transport system
SE9303281D0 (sv) * 1993-10-07 1993-10-07 Astra Ab New formulation
GB9322007D0 (en) * 1993-10-26 1993-12-15 Unilever Plc Cosmetic composition
JPH09507233A (ja) * 1993-12-29 1997-07-22 マトリクス ファーマスーティカル，インコーポレイティド 細胞増殖性疾患に罹る宿主の治療方法及び治療のための組成物
FR2714595B1 (fr) * 1993-12-30 1996-02-02 Oreal Emulsion eau dans huile contenant du rétinol, son utilisation et son conditionnement.
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5514698A (en) * 1994-03-21 1996-05-07 Ortho Pharmaceutical Corporation Antifungal vaginal cream composition
AU3633295A (en) * 1994-09-07 1996-03-27 Johnson & Johnson Consumer Products, Inc. Retinoid compositions
US5976555A (en) * 1994-09-07 1999-11-02 Johnson & Johnson Consumer Products, Inc. Topical oil-in-water emulsions containing retinoids
US6461622B2 (en) * 1994-09-07 2002-10-08 Johnson & Johnson Consumer Companies, Inc. Topical compositions
US5567420A (en) * 1994-11-16 1996-10-22 Mceleney; John Lotion which is temporarily colored upon application
US5871760A (en) 1994-11-28 1999-02-16 The Procter & Gamble Company Skin care compositions
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
US6413536B1 (en) * 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
CA2224173C (en) * 1995-06-08 2007-09-18 Johnson & Johnson Consumer Companies, Inc. Sunscreen compositions
EP2314272A1 (en) * 1995-06-22 2011-04-27 Minnesota Mining And Manufacturing Company Stable hydroalcoholic compositions
AU715827B2 (en) * 1995-06-22 2000-02-10 Minnesota Mining And Manufacturing Company Stable hydroalcoholic compositions
US5665364A (en) 1995-07-24 1997-09-09 The Procter & Gamble Company Compositions for topical delivery of active ingredients
US6383499B1 (en) * 1995-10-30 2002-05-07 Curacid America Corporation Topical medicament for the treatment of psoriasis
US5738856A (en) * 1995-11-03 1998-04-14 Ocular Research Of Boston, Inc. Skin care preparation and method
US5744148A (en) * 1996-09-20 1998-04-28 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Stabilization of an unstable retinoid in oil-in-water emulsions for skin care compositions
JPH10112566A (ja) * 1996-10-07 1998-04-28 Furukawa Electric Co Ltd:The 半導体レーザ
US5997890A (en) * 1997-05-23 1999-12-07 The Procter & Gamble Company Skin care compositions and method of improving skin appearance
US5972359A (en) * 1997-05-23 1999-10-26 The Procter & Gamble Company Skin care compositions and method of improving skin appearance
US6174533B1 (en) * 1997-05-23 2001-01-16 The Procter & Gamble Company Skin care compositions and method of improving skin appearance
US6001377A (en) * 1997-05-23 1999-12-14 The Procter & Gamble Company Skin care compositions and method of improving skin appearance
EP0882498B1 (en) * 1997-06-02 2004-02-11 Hodogaya Chemical Co Ltd Process for producing a solvent-less O/W type emulsion
ES2170522T5 (es) * 1997-08-18 2011-11-14 NEUBOURG SKIN CARE GMBH & CO. KG Crema cutánea espumosa.
US5935589A (en) * 1997-10-17 1999-08-10 Chesebrough-Pond's Usa Co. Stable cosmetic compositions with different pH emulsions
JP3971495B2 (ja) 1998-01-09 2007-09-05 富士通コンポーネント株式会社 回転角度検出装置
FR2781149B1 (fr) * 1998-07-17 2001-09-07 Oreal Composition deodorante contenant un sel d'alun
US6030623A (en) * 1998-10-30 2000-02-29 Meade; William H. Medical extract from plant
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6268985B1 (en) * 1999-03-30 2001-07-31 International Business Machines Corporation Read head having spin valve sensor with improved capping layer
CA2364556A1 (en) * 1999-04-07 2000-10-19 Ciba Specialty Chemicals Holding Inc. Liquid dispersion polymer compositions, their preparation and their use
KR100627530B1 (ko) 1999-05-06 2006-09-22 동아제약주식회사 히드로퀴논, 트레티노인 및 히드로코티손을 함유하는 흑피증치료제용 조성물
US6200964B1 (en) * 1999-05-28 2001-03-13 Neutrogena Corporation Silicone gel containing salicylic acid
CA2358958C (en) 1999-11-05 2012-07-31 Johnson & Johnson Consumer Companies, Inc. Soy depigmenting and skin care compositions
FR2833841B1 (fr) 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
CA2495043A1 (en) 2002-09-05 2004-03-18 Isabelle Pelisson Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent
US7544674B2 (en) * 2002-10-25 2009-06-09 Galderma S.A. Topical skin care composition
US20060099173A1 (en) * 2003-10-24 2006-05-11 Nancy Puglia Topical skin care composition
TWI307815B (en) * 2006-07-05 2009-03-21 Young Optics Inc Lens module
WO2008074848A1 (en) * 2006-12-19 2008-06-26 Galderma S.A. Method of using fluocinolone acetonide, tretinoin and hydroquinone cream in melasma maintenance therapy
CA2671530A1 (en) * 2006-12-19 2008-06-26 Galderma S.A. Use of fluocinolone acetonide,tretinoin and hydroquinone cream in melasma maintenance therapy

Also Published As

Publication number Publication date
AU2003284353B2 (en) 2009-07-16
CN1738587A (zh) 2006-02-22
PL376715A1 (pl) 2006-01-09
US20140171399A1 (en) 2014-06-19
US20160193121A1 (en) 2016-07-07
JP5528973B2 (ja) 2014-06-25
US20040081668A1 (en) 2004-04-29
AU2003284353A1 (en) 2004-05-13
JP2006507285A (ja) 2006-03-02
US20110178051A1 (en) 2011-07-21
AU2003284353B9 (en) 2010-01-28
KR20060040755A (ko) 2006-05-10
BRPI0314882B1 (pt) 2018-01-02
US9333172B2 (en) 2016-05-10
MXPA05004404A (es) 2006-02-10
EP1562531A2 (en) 2005-08-17
US7544674B2 (en) 2009-06-09
US7939516B2 (en) 2011-05-10
KR20050083828A (ko) 2005-08-26
US8247395B2 (en) 2012-08-21
CY1117292T1 (el) 2017-04-26
US7915243B2 (en) 2011-03-29
EP1562531A4 (en) 2011-12-21
US20070207988A1 (en) 2007-09-06
KR100852367B1 (ko) 2008-08-14
RU2005115856A (ru) 2006-01-20
US20120263666A1 (en) 2012-10-18
ES2565317T3 (es) 2016-04-01
HK1088831A1 (en) 2006-11-17
CA2503539A1 (en) 2004-05-06
JP4638234B2 (ja) 2011-02-23
AU2003284353A2 (en) 2004-05-13
CN1738587B (zh) 2010-05-12
BR0314882A (pt) 2005-08-09
KR100851789B1 (ko) 2008-08-13
SI1562531T1 (sl) 2016-04-29
WO2004037201A3 (en) 2004-10-21
US8653053B2 (en) 2014-02-18
PL219020B1 (pl) 2015-02-27
DK1562531T3 (en) 2016-04-11
EP3002004A1 (en) 2016-04-06
HUE028549T2 (en) 2016-12-28
JP2010280738A (ja) 2010-12-16
US20100125057A1 (en) 2010-05-20
HK1223040A1 (zh) 2017-07-21
EP1562531B1 (en) 2016-01-13
WO2004037201A2 (en) 2004-05-06
PT1562531E (pt) 2016-03-31
RU2350313C2 (ru) 2009-03-27
US20050101580A1 (en) 2005-05-12

Similar Documents

Publication Publication Date Title
BRPI0314882B8 (pt) processo para preparar uma composição tópica contendo acetonida de fluocinolona, hidroquinona e tretinonína para aplicação tópica e composição
HK1048764A1 (en) Oligosaccaride aldonic acids and their topical use
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
MX9501848A (es) Nuevos compuestos polienicos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
PT784481E (pt) Formulacoes para cicatrizacao de feridas contendo fibronectina do plasma humano
PT751778E (pt) Utilizacao de agua com teor reduzido de deuterio para a producao de preparacoes higienicas e cosmeticas
BR9707153A (pt) Compostos biaromáticos composição farmacêutica composição cosmética e utilização de uma composição cosmética
ES2161888T3 (es) Utilizacion de la laminarina y de los oligosacaridos derivados de laminarina en cosmetologia y para la fabricacion de un medicamento destinado al tratamiento de la piel.
NZ328874A (en) Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders
ES2113222T3 (es) Utilizacion de derivados de acido benzoico para estimular el proceso de renovacion epidermica y tratar la piel.
PL330865A1 (en) Agents containing lectins and their application
PL323363A1 (en) Biaromatic propynyl or dienyl compounds
WO2004034958A3 (en) Use of amide or ester of sugar and of fatty acid, for treating and/or preventing dry skin
MXPA03011622A (es) Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas.
DE60027127D1 (de) Verwendung von Polyaminosäurederivaten zur Behandlung von Seborrhoe und verwandten Hautstörungen
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
EP1578780A4 (en) PROCESS FOR INCREASING FIBRONECTIN
DE59409869D1 (de) Hormonales mittel zur therapie der akne und dessen verwendung
HUP0200005A2 (hu) Gyógyszerkészítmény a pszoriázis kezelésére és eljárás az előállítására
HUP0204180A2 (hu) Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére
DE69901843D1 (de) Eine oder mehrere komponente des perlmuttes einschliesslich bio-aragonit enthaltendes homeopathisches arzneimittel
MD20050055A (ro) Metodă de tratament al bolii vitiligo
AR015551A1 (es) Utilizacion de al menos un inhibidor de la actividad del acido retinoico, productos que comprenden a dicho inhibidor y procedimientos de tratamiento noterapeutico para retrasar o impedir el crecimiento de los pelos, o para retrasar la caida de los pelos y/o de los cabellos
MX9605916A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en para, composiciones farmaceuticos y cosmeticas que los contienen y utilizaciones.
BR0202538A (pt) Embalagem aplicadora de produtos protetores para pele e método de produção da mesma

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: GALDERMA S.A. (CH)

Free format text: TRANSFERIDO DE: HILL DERMACEUTICALS, INC.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 6/00 , A61K 7/00 , A61K 31/74 , A01N 25/00

Ipc: A61K 31/05 (2006.01), A61K 31/203 (2006.01), A61K

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/10/2003 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.